Quibim, a global leader in quantitative medical imaging solutions, today announced that its flagship solution, QP-Prostate, ...

For only the second time in almost a quarter of a century, Cancer Research UK is seeking a new headline partner for its Race ...

A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...

Anal cancer is a rare yet increasing cancer linked primarily to high-risk HPV strains such as HPV-16 and HPV-18. Key risk factors include weakened immune systems, age over 50, and high-risk sexual ...

A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...

The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...

Scientists have developed a new technique described as a ‘powerful double weapon’ to help patients keep their hair. It ...

The cancer cachexia market is expected to witness an expansion across the 7MM, driven by the introduction of innovative therapies, ponsegromab (PF-06946860), S-pindolol benzoate (ACM-001.1) ...

Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...

Salisbury's Cancer Research UK fundraising team, which has generated £2m, has celebrated its 75-year anniversary ...

Cancer Research UK has awarded £457,000 to support a pioneering study in Cambridge that could play a pivotal role in the ...

People dying early from cancer costs the UK economy £10.3 billion a year, according to the most comprehensive analysis of its kind.